Vitamin B-12

Verify with FDA CVM →

10 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
4
Deaths Reported
4000.0%
Death Rate

Active Ingredients

Vitamin B-12

Administration Routes

SubcutaneousUnknownParenteral

Species Affected

Dog 5
Cat 5

Most Affected Breeds

Domestic Shorthair 5
Retriever - Labrador 2
Chihuahua 1
Terrier (unspecified) 1
Beagle 1

Most Reported Reactions

Vomiting 2
Death 2
Dermatitis 2
Elevated alanine aminotransferase (ALT) 2
Death by euthanasia 2
Elevated total bilirubin 2
Decreased appetite 1
Drinking a lot 1
Frequent urination 1
Hyperglycaemia 1
Unsteady gait 1
Elevated blood urea nitrogen (BUN) 1

Outcome Breakdown

Ongoing
3 (30.0%)
Died
2 (20.0%)
Euthanized
2 (20.0%)
Outcome Unknown
2 (20.0%)
Recovered/Normal
1 (10.0%)

Data Summary

Metric Value
Total adverse event reports 10
Reports involving death 4
Case-fatality rate (reported events) 4000.0%
Distinct species in reports 2
Distinct breeds in reports 5
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Vitamin B-12 Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 10 adverse event reports referencing Vitamin B-12, including 4 reports in which the animal died — a 4000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Vitamin B-12. Reported administration routes include Subcutaneous, Unknown, Parenteral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Vitamin B-12 reports are Dog (5 reports), Cat (5 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (5), Retriever - Labrador (2), Chihuahua (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Vitamin B-12 are Vomiting (2), Death (2), Dermatitis (2), Elevated alanine aminotransferase (ALT) (2). Of the 10 reports with a coded outcome, Ongoing is the leading category at 30.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Vitamin B-12.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial